✦ LIBER ✦

What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?

✍ Scribed by Stéphane Oudard; Eugeniu Banu; Jacques Medioni; Florian Scotte; Adela Banu; Eric Levy; Johana Wasserman; Gabriel Kacso; Jean-Marie Andrieu

Book ID: 109055569
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 221 KB
Volume: 103
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2008.08283.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The risk of renal impairment in hormone-

The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid

✍ William K. Oh; Kevin Proctor; Mari Nakabayashi; Carolyn Evan; Lauren K. Tormey; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Phosphorylation of the androgen receptor

Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients

✍ McCall, P; Gemmell, L K; Mukherjee, R; Bartlett, J M S; Edwards, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 282 KB

Bone histology at autopsy and matched bo

Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: The effect of bisphosphonate therapy on bone scintigraphy results

✍ M.P. Roudier; H. Vesselle; L.D. True; C.S. Higano; S.M. Ott; S.H. King; R.L. Ves 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 478 KB